[go: up one dir, main page]

LU et al., 2006 - Google Patents

Induction of the Epstein‐Barr Virus Latent Membrane Protein 2 Antigen‐specific Cytotoxic T Lymphocytes Using Human Leukocyte Antigen Tetramer‐based Artificial …

LU et al., 2006

View PDF
Document ID
795765667226728427
Author
LU X
LIANG Z
ZHANG C
LU S
WENG X
WU X
Publication year
Publication venue
Acta biochimica et biophysica Sinica

External Links

Snippet

Cytotoxic T lymphocytes (CTLs) specific for the Epstein‐Barr virus (EBV) latent membrane protein 2 (LMP2) antigen are important reagents for the treatment of some EBV‐associated malignancies, such as EBV‐positive Hodgkin's disease and nasopharyngeal carcinoma …
Continue reading at academic.oup.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells

Similar Documents

Publication Publication Date Title
US20230145991A1 (en) T cell compositions for immunotherapy
Neudorfer et al. Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor-and virus-derived antigens
Ho et al. In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire
AU2017330379B2 (en) Generation and use in adoptive immunotherapy of stem cell-like memory T cells
WO2019157298A1 (en) Methods for manufacturing t cells
Heemskerk et al. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells
JP2018509911A (en) Method for detecting a novel immunogenic T cell epitope using MHC cell library and method for isolating a novel antigen-specific T cell receptor
Salgaller et al. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide
CN107709351A (en) Cytotoxic t cell epitope peptide for sars and application thereof
JP2025028931A (en) EBV-specific immune cells
Khalaf et al. In vitro generation of cytotoxic T cells with potential for adoptive tumor immunotherapy of multiple myeloma
Röpke et al. T cell‐mediated cytotoxicity against p53‐protein derived peptides in bulk and limiting dilution cultures of healthy donors
Kubuschok et al. Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model
Motta et al. In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density
LU et al. Induction of the Epstein‐Barr Virus Latent Membrane Protein 2 Antigen‐specific Cytotoxic T Lymphocytes Using Human Leukocyte Antigen Tetramer‐based Artificial Antigen‐presenting Cells
Adamopoulou et al. Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response
JP2019110909A (en) Epitope peptides of cytotoxic t lymphocyte and uses thereof
WO2001077302A1 (en) Method for obtaining specific t-lymphocytes, and for identifying unknown epitopes
Kammula et al. Use of high throughput qPCR screening to rapidly clone low frequency tumour specific T-cells from peripheral blood for adoptive immunotherapy
AU2017415310B2 (en) Use of the IL-15/IL-15Rα complex in the generation of antigen-specific T cells for adoptive immunotherapy
Hasan et al. Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies
Pancholi et al. An approach to isolating T cell lines that react to antigens presented on the surface of dendritic cells
Meckiff Evolution of the human CD4+ T cell response to Epstein-Barr virus infection-analysis of systemic and local immune responses
Weng et al. Peptide-specific, allogeneic T cell response in vitro induced by a self-peptide binding to HLA-A2
Jeras et al. Induction/Engineering, Detection, Selection, and Expansion of Clinical‐Grade Human Antigen‐Specific CD8+ Cytotoxic T Cell Clones for Adoptive Immunotherapy